About SP Pharmaceuticals
SP Pharmaceuticals is a Healthcare company based in Jalgaon (India) founded in 1996. Pharmaceutical tablets, liquids, and granules are manufactured for therapeutic needs. Its chief executive, as recorded, is Ashish Garg. Its Indian entity Anuvaa Softech Private Limited reported revenue of ₹3.8 Lakh. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
SP Pharmaceuticals was founded in 1996 and is based in Jalgaon, India. Operations focus on the pharmaceutical sector, where tablets, liquids, and granules are produced for conditions such as Alzheimers disease, depression, diabetes, epilepsy, and schizophrenia. Various dosage forms are offered to address patient requirements. Stringent quality control and assurance standards are followed in manufacturing. Technology transfer and formulation development services are provided to support industry needs.
- Headquarters Jalgaon, India
- SectorsHealthcare
- Email••••••••
- Website sppharmaceuticals.com
- Social LinkedIn
- Legal Name Anuvaa Softech Private Limited
- Date of Incorporation 15 Apr, 2015
- Jurisdiction Jalgaon, Maharashtra, India
- Annual Revenue₹3.8 Lakh
FY 2016
- Net Profit₹4,042
FY 2016 · 1% margin
- EBITDA₹26,243
FY 2016 · 7% margin
- Investors
Associated legal entities of SP Pharmaceuticals
SP Pharmaceuticals operates through Anuvaa Softech Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2016) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Anuvaa Softech Private Limited CIN U72502MH2015PTC263488 | Strike Off | 15 Apr 2015 | Jalgaon, Maharashtra | ₹0.0 Cr | 3 | View details |
Funding Insights of SP Pharmaceuticals
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of SP Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 1997 | Private Equity Round | – | – |
1 investors in total: 1 institutional.
Investors in SP Pharmaceuticals
SP Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ridgemont Equity partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Mid-market companies are invested in by this private equity firm. | ridgemontep.com | Charlotte, United States |
Investor details for SP Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Anuvaa Softech Private Limited (SP Pharmaceuticals)
Anuvaa Softech Private Limited is the primary company behind SP Pharmaceuticals. The board of Anuvaa Softech Private Limited currently have 3 directors; the longest-serving is Bhushan Dilip Savale, appointed in 2015. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bhushan Dilip Savale DIN 07055564 | Director | 15 Apr 2015 | 11 yrs 6 mo | Anuvaa Softech Private Limited |
| Mayur Samadhan Potdar DIN 07055798 | Manager | 15 Apr 2015 | 11 yrs 6 mo | Anuvaa Softech Private Limited |
| Amit Anil Manore DIN 07675209 | Additional Director | 21 Feb 2017 | 9 yrs 8 mo | Anuvaa Softech Private Limited |
People of SP Pharmaceuticals
1 people are tracked at SP Pharmaceuticals (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ashish Garg | CEO | Leadership |
Complete people profiles for SP Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SP Pharmaceuticals
Figures of Anuvaa Softech Private Limited, the primary company behind SP Pharmaceuticals, for FY 2016. Revenue was ₹3.8 Lakh. Net profit was ₹4,042 (1% margin). EBITDA was ₹26,243 (7% margin).
- ₹3.8 LakhRevenue · FY 2016
- ₹4,042Net profit · 1% margin
- ₹26,243EBITDA · 7% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Anuvaa Softech Private Limited are on its company page.
Detailed financial statements for SP Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of SP Pharmaceuticals
2 dated milestones of SP Pharmaceuticals across 1 years, from founding to its latest funding, stage changes and deals.
- Founded SP Pharmaceuticals is founded.
- Funding First funding round.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as SP Pharmaceuticals (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SP Pharmaceuticals
SP Pharmaceuticals was founded in 1996 and raised its 1st funding round 1 year after it was founded.
SP Pharmaceuticals is headquartered in Jalgaon, India. It is registered at Jalgaon, Maharashtra, India.
Ashish Garg is the CEO of SP Pharmaceuticals, as recorded in our data.
The primary company behind SP Pharmaceuticals, Anuvaa Softech Private Limited, reported revenue of ₹3.8 Lakh for FY 2016.
SP Pharmaceuticals was founded in 1996 and is based in Jalgaon, India. Operations focus on the pharmaceutical sector, where tablets, liquids, and granules are produced for conditions such as Alzheimers disease, depression, diabetes, epilepsy, and schizophrenia. Various dosage forms are offered to address patient requirements. Stringent quality control and assurance standards are followed in manufacturing. Technology transfer and formulation development services are provided to support industry needs.
SP Pharmaceuticals has 1 investor. Key investors include Ridgemont Equity partners.
SP Pharmaceuticals operates through Anuvaa Softech Private Limited.
The legal entities of SP Pharmaceuticals currently have 3 directors, including Amit Anil Manore, Bhushan Dilip Savale, Mayur Samadhan Potdar.